Upstate Active Clinical Trials
Study Title:A Phase 1B, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosentuzumab to Participants with Systemic Lupus Erythemastosus. GA43191
Upstate Institutional Review Board (IRB) Number:1821375
Patient Age Group:Adults
Principal Investigator:Andras Perl, MD, PhD
Who can I contact for more information?
Name: Joanne M Chilton, CCRP